On July 28, 2009, the FDA published a final rule requiring holders of new drug applications (NDAs) to submit certain information regarding authorized generic drugs in an annual report. The FDA is taking this action as part of its implementation of the Food and Drug Administration Amendments Act of 2007, which requires the FDA to provide updated listings of all authorized generic drugs. The rule is effective January 25, 2010.